S. Pond

发表

Enhancers Are Major Targets for Murine Leukemia Virus Vector Integration

Michael Poidinger, Stephen H. Hughes, Janet L. Macpherson, 2014, Journal of Virology.

Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog.

M. Roberts, S. Pond, L. Rivory, 1993, Journal of toxicology. Clinical toxicology.

Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase.

J. Robert, S. Pond, L. Rivory, 1996, Biochemical pharmacology.

Safety and Efficacy of Autologous CD34+ Hematopoietic Progenitor Cells Transduced with an Anti-Tat Ribozyme in a Multi-Center, Randomized, Placebo-Controlled, Phase II Gene Therapy Trial for the Human Immunodeficiency Virus

C. von Kalle, T. Merigan, M. Winters, 2009, Nature Medicine.

Urinary excretion of the N-acetyl cysteine conjugate of cis-1,3-dichloropropene by exposed individuals.

B. S. Cohen, J. Osterloh, S. Pond, 1984, Archives of environmental health.

Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients.

J. Robert, S. Pond, J. Riou, 1996, Cancer research.

Studies of protein interactions by biosensor technology: an alternative approach to the analysis of sensorgrams deviating from pseudo-first-order kinetic behavior.

D. Winzor, S. Pond, M. Bowles, 1997, Analytical biochemistry.

Effects of paraquat on canine bronchoalveolar lavage fluid.

D. Eyles, S. Pond, E. Hampson, 1989, Toxicology and applied pharmacology.

Quantitation of paraquat in biological samples by radioimmunoassay using a monoclonal antibody.

D. Eyles, S. Pond, E. Hampson, 1992, Fundamental and applied toxicology : official journal of the Society of Toxicology.

The Puzzle of Rates of Cellular Uptake of Protein-Bound Ligands

S. Pond, L. Bass, 1988 .

Albumin enhances unidirectional fluxes of fatty acid across a lipid-water interface: theory and experiments.

S. Pond, R. Weisiger, L. Bass, 1989, The American journal of physiology.

Hepatic uptake of protein-bound ligands: extended sinusoidal perfusion model.

S. Pond, R. Weisiger, L. Bass, 1991 .

Hepatic uptake of protein-bound ligands: extended sinusoidal perfusion model.

S. Pond, R. Weisiger, L. Bass, 1991, The American journal of physiology.

Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism

D. Effeney, S. Pond, T. Tozer, 1987, Journal of Pharmacokinetics and Biopharmaceutics.

Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragments.

S. Pond, P. Pentel, M. Bowles, 1988, International journal of immunopharmacology.

Prevention of Paraquat Toxicity in Suspensions of Alveolar Type II Cells by Paraquat-Specific Antibodies

S. Pond, M. Bowles, Nian Chen, 1994, Human & experimental toxicology.

Bound Tris confounds the identification of binding site residues in a paraquat single chain antibody.

T. Mulhern, S. Pond, I. Sharpe, 1997, Journal of biochemistry.

Production of a paraquat-specific murine single chain Fv fragment.

C. Devlin, S. Pond, M. Bowles, 1995, Journal of biochemistry.

Comparison of paraquat-specific murine monoclonal antibodies produced by in vitro and in vivo immunization.

D. Winzor, S. Pond, M. Bowles, 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

The dopamine transporter gene and Parkinson's disease in a Chinese population

J. Woo, D. L. Le Couteur, R. Kay, 1997, Neurology.

Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease

D. L. Le Couteur, S. Pond, S. J. McCann, 1997, Movement disorders : official journal of the Movement Disorder Society.

Uptake of palmitate by hepatocyte suspensions: facilitation by albumin?

M. Bogoyevitch, S. Pond, R. Weisiger, 1992, The American journal of physiology.

An evaluation of the effects of lithium in the treatment of chronic alcoholism. II. Assessment of the two-period crossover design.

C. Peck, K. Lee, S. Pond, 1981, Alcoholism, clinical and experimental research.

Toxicologic studies in a fatal overdose of 2,4-D, MCPP, and chlorpyrifos.

J. Osterloh, S. Pond, M. Lotti, 1983, Journal of analytical toxicology.

Prescription for poisoning

S. Pond, 1995, The Medical journal of Australia.

Metabolism of haloperidol to pyridinium species in patients receiving high doses intravenously: is HPTP an intermediate?

C. J. Van der Schyf, G. Fraser, R. Riker, 1997, Life sciences.

Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia

D. Eyles, S. Pond, A. Jones, 1994, Clinical pharmacology and therapeutics.

Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.

J. Miners, L. Sansom, S. Pond, 1991, British journal of clinical pharmacology.

Mechanisms of inhibition of tolbutamide metabolism: Phenylbutazone, oxyphenbutazone, sulfaphenazole

S. Pond, D. Wade, D. Birkett, 1977, Clinical pharmacology and therapeutics.

Combined hepatic and renal injury in alcoholics during therapeutic use of acetaminophen.

S. Pond, G. Kaysen, M. Roper, 1985, Archives of internal medicine.

The effects of differential induction of cytochrome P-450, carboxylesterase and glutathione S-transferase activities on malathion toxicity in mice.

S. Pond, A. Ketterman, C. Becker, 1987, Toxicology and applied pharmacology.

Haloperidol-Derived Pyridinium Metabolites

S. Pond, C. J. Schyf, N. Castagnoli, 1998 .

Metabolic defects caused by treatment with the tetrahydropyridine analog of haloperidol (HPTP), in baboons.

C. J. Van der Schyf, S. Pond, N. Castagnoli, 1997, Life sciences.

ILLUMINATION OF THERAPEUTICS BY TOXICOLOGY: A PERSONAL VIEW *

S. Pond, 1996, Clinical and experimental pharmacology & physiology.

Effects of lipophilicity and protein binding on the hepatocellular uptake and hepatic disposition of two anthracyclines, doxorubicin and iododoxorubicin

S. Pond, L. Rivory, K. Avent, 1996, Cancer Chemotherapy and Pharmacology.

Activation of the food-derived mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450.

I. Stupans, S. Pond, M. McManus, 1989, Carcinogenesis.

Purification and characterization of two human liver carboxylesterases.

S. Pond, A. Ketterman, M. Bowles, 1989, The International journal of biochemistry.

Diflunisal and its conjugates in patients with renal failure.

S. Pond, R. Verbeeck, R. Dickinson, 1991, British journal of clinical pharmacology.

The influence of pH on the interaction of lipophilic anthracyclines with bovine serum albumin. Quantitative characterization by measurement of fluorescence quenching.

D. Winzor, S. Pond, L. Rivory, 1992, Biochemical pharmacology.

Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol.

H. Whiteford, D. Eyles, S. Pond, 1991, Biochemical and biophysical research communications.

Disposition of epirubicin after intraarterial administration in Lipiodol to patients with hepatocellular carcinoma.

S. Pond, H. Dodds, L. Rivory, 1996, Therapeutic drug monitoring.

Management of Theophylline Overdose Patients in the Intensive Care Unit

S. Pond, D. M. Wright, A. Henderson, 1992, Anaesthesia and intensive care.

Effects of tricyclic antidepressants on drug metabolism

G. Graham, S. Pond, D. Wade, 1975, Clinical pharmacology and therapeutics.

Potential pitfalls in the evaluation of the usefulness of hemodialysis for the removal of lithium.

S. Pond, C. Becker, N. Clendeninn, 1982, Journal of toxicology. Clinical toxicology.

Pharmacokinetics of Drug Overdose

N. Benowitz, S. Pond, J. Rosenberg, 1981, Clinical pharmacokinetics.

Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry.

S. Pond, P. Taylor, A. Jones, 1996, Clinical chemistry.

The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose

S. Pond, D. O’Connell, J. Leitch, 2003, Critical care.

Gastric emptying in acute overdose: a prospective randomised controlled trial

S. Pond, D. Lewis-Driver, A. Green, 1995, The Medical journal of Australia.

Survival After Unexpected High Serum Methotrexate Concentrations in a Patient with Osteogenic Sarcoma

S. Pond, P. Ravenscroft, R. Whiting, 1990, Drug safety.

Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells

S. Pond, L. Bryan-Lluka, G. Siebert, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

Dopamine receptor binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)- 4-oxobutyl]-1,2,3,6-tetrahydropyridine (HPTP), an intermediate metabolite of haloperidol.

C. J. Van der Schyf, S. Pond, N. Castagnoli, 1996, Life sciences.

Massive catecholamine release from caffeine poisoning.

N. Benowitz, J. Osterloh, S. Pond, 1982, JAMA.

Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver.

N. Benowitz, P. Jacob, S. Pond, 1980, Australian and New Zealand journal of medicine.

Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.

G. Brunn, S. Pond, D. Keyler, 1991, Drug metabolism and disposition: the biological fate of chemicals.

Manifestations and management of paraquat poisoning

S. Pond, 1990, The Medical journal of Australia.

Phenytoin-induced methadone withdrawal.

N. Benowitz, M. Kreek, S. Pond, 1981, Annals of internal medicine.

Cortisol metabolism and its inhibition by glycyrrhetinic acid in the isolated perfused human placental lobule

G. R. Cannell, S. Pond, P. Taylor, 1997, The Journal of Steroid Biochemistry and Molecular Biology.

Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboon.

C. J. Van der Schyf, D. Eyles, S. Pond, 1996, Life sciences.

Redistribution into plasma of tracer doses of desipramine by anti-desipramine antiserum in rats.

S. Pond, P. Pentel, D. Schoof, 1987, Biochemical pharmacology.

Biliary excretion of diflunisal conjugates in patients with T-tube drainage

S. Pond, R. Verbeeck, R. Dickinson, 2004, European Journal of Clinical Pharmacology.

Formation of pyridinium species of haloperidol in human liver and brain

D. Eyles, S. Pond, D. Eyles, 1996, Psychopharmacology.

Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration.

D. Effeney, S. Pond, R. Fielding, 1985, The Journal of pharmacology and experimental therapeutics.

Dose-dependent bioavailability and metabolism of salicylamide in dogs.

D. Effeney, W. Couet, S. Pond, 1984, The Journal of pharmacology and experimental therapeutics.

Role of Repeated Oral Doses of Activated Charcoal in Clinical Toxicology

S. Pond, 1986, Medical toxicology.

Effects on the liver of chemicals encountered in the workplace.

S. Pond, 1982, The Western journal of medicine.

Liver Damage in Nurses Handling Cytostatic Agents

S. Pond, 1984 .

An assessment of the potential testicular toxicity of 10 pesticides using the mouse-sperm morphology assay.

J. Osterloh, S. Pond, C. Becker, 1983, Mutation research.

Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivo.

H. Whiteford, J. Csernansky, S. Pond, 1993, Life sciences.

Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem.

D. Eyles, S. Pond, T. Stedman, 1997, Life sciences.

Experience with 732 acute overdose patients admitted to an intensive care unit over six years

S. Pond, A. Henderson, M. Wright, 1993, The Medical journal of Australia.

Determination of methadone and its primary metabolite in biologic fluids using gas chromatography with nitrogen-phosphorus detection.

N. Benowitz, P. Jacob, S. Pond, 1981, Journal of Analytical Toxicology.

Outbreak of Illness in a School Chorus

S. Pond, 1983 .

Oleander interference in the digoxin radioimmunoassay in a fatal ingestion.

J. Osterloh, S. Pond, S. Herold, 1982, JAMA.

Serum formate concentrations in methanol intoxication as a criterion for hemodialysis.

J. Osterloh, S. Pond, C. Becker, 1986, Annals of internal medicine.

Analysis of salicylamide and its metabolites in blood and urine by HPLC

S. Pond, R. Fielding, T. Tozer, 1984 .

Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

Christof von Kalle, Roger Garsia, Robert Finlayson, 2009, Nature medicine.

Amanita phalloides-type mushroom poisoning.

S. Pond, C. E. Becker, K. Olson, 1982, The Western journal of medicine.

T-lymphocyte perturbation following large-scale apheresis and hematopoietic stem cell transplantation in HIV-infected individuals.

A. Kelleher, J. Zaunders, J. Macpherson, 2012, Clinical immunology.

Chirality of reduced haloperidol in humans

D. Eyles, S. Pond, T. Stedman, 1998, European Neuropsychopharmacology.

Stereospecific reduction of haloperidol in human tissues.

D. Eyles, S. Pond, 1992, Biochemical pharmacology.

Amatoxin poisoning in northern California, 1982-1983.

J. Osterloh, S. Pond, R. E. Ward, 1986, The Western journal of medicine.

Treatment of mushroom poisoning.

S. Pond, K. Olson, O. Woo, 1984, JAMA.

Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients.

H. Whiteford, J. Welham, D. Eyles, 1991, Journal of clinical psychopharmacology.

Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells

S. Pond, L. Bryan-Lluka, G. Siebert, 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis

D. L. Le Couteur, S. Pond, S. J McCann, 1997, Journal of the Neurological Sciences.

First-Pass Elimination Basic Concepts and Clinical Consequences

S. Pond, T. Tozer, T N Tozer, 1984, Clinical pharmacokinetics.

Polyclonal amanitin-specific antibodies: production and cytoprotective properties in vitro.

S. Pond, M. Bowles, N. Chen, 1993, Biochemical Pharmacology.

Adaptation of the Müller method to allow quantitative characterization of the affinity and cross-reactivity of antibodies by competitive radioimmunoassay.

D. Winzor, S. Pond, P. Pentel, 1991, Molecular immunology.

Effect of phenytoin on meperidine clearance and normeperidine formation

S. Pond, K Merlin Kretschzmar, 1981, Clinical pharmacology and therapeutics.

Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects

N. Benowitz, P. Jacob, S. Pond, 1981, Clinical pharmacology and therapeutics.

Gas chromatographic analysis of meperidine and normeperidine: determination in blood after a single dose of meperidine.

N. Benowitz, P. Jacob, S. Pond, 1982, Journal of pharmaceutical sciences.

A high-performance liquid chromatography-electrospray-tandem mass spectrometry analysis of cortisol and metabolites in placental perfusate.

G. R. Cannell, S. Pond, P. Taylor, 1997, Analytical biochemistry.

Temperature transitions of the microsomal hydroxylation system

S. Pond, D. Wade, D. Birkett, 1977 .

Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs

M. Roberts, S. Pond, L. Rivory, 1992, Journal of Pharmacokinetics and Biopharmaceutics.

Why Medical Toxicology?

L. Goldfrank, S. Pond, L. Prescott, 1986 .

Continuous Arteriovenous Hemofiltration for Paraquat Poisoning

S. Pond, S. Johnston, J. Petrie, 1986 .

Massive intoxication with acetaminophen and propoxyphene: unexpected survival and unusual pharmacokinetics of acetaminophen.

S. Roberts, S. Pond, G. Levy, 1982, Journal of toxicology. Clinical toxicology.

Hepatic intracellular pH during the prereplicative period following partial hepatectomy.

D. L. Le Couteur, S. Pond, L. Rivory, 1993, The American journal of physiology.

The effects of allopurinol and clofibrate on the elimination of coumarin anticoagulants in man.

G. Sudlow, G. Graham, S. Pond, 1975, Australian and New Zealand journal of medicine.

Sensitive high-performance liquid chromatographic assay with ultraviolet detection of methadone enantiomers in plasma.

S. Pond, P. Ravenscroft, R. Norris, 1994, Journal of chromatography. B, Biomedical applications.

Extracorporeal techniques in the treatment of poisoned patients: In Reply

S. Pond, 1991, The Medical journal of Australia.

Failure of Haemoperfusion and Haemodialysis to Prevent Death in Paraquat Poisoning

S. Pond, E. Hampson, 1988, Medical toxicology and adverse drug experience.

Sex differences in initial clearance of palmitate by human hepatocytes

S. Pond, L. Bass, R. A. Gordon, 1996, European journal of clinical investigation.

Ultrastructure of canine lung during the proliferative phase of paraquat toxicity.

S. Pond, E. Hampson, 1988, British journal of experimental pathology.

Impaired metabolism of methylphenobarbital after a combined drug overdose: treatment by resin hemoperfusion.

P. Jacob, S. Pond, M. Humphreys, 1982, Journal of toxicology. Clinical toxicology.

Effects of gender and pregnancy on hepatocellular uptake of palmitic acid: facilitation by albumin.

S. Pond, R. Weisiger, L. Bass, 1994, The American journal of physiology.

Calibration of albumin-fatty acid binding constants measured by heptane-water partition.

F. Burczynski, S. Pond, R. Weisiger, 1993, The American journal of physiology.

Further observations on the measurement of fatty acid incorporation by erythrocyte ghosts to quantify unbound palmitate concentration in albumin-palmitate mixtures.

D. Winzor, S. Pond, R. A. Gordon, 1996, Analytical biochemistry.

Two fatalities after acute occupational exposure to ethylene dibromide.

J. Osterloh, S. Pond, C. Becker, 1984, JAMA.

Theophylline overdose: acute single ingestion versus chronic repeated overmedication.

N. Benowitz, S. Pond, K. Olson, 1985, The American journal of emergency medicine.

Benefit of hemoperfusion in acute theophylline intoxication.

N. Benowitz, S. Pond, K. Olson, 1984, Journal of toxicology. Clinical toxicology.

Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal.

J. Osterloh, S. Pond, K. Olson, 1984, JAMA.

Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms

D. Eyles, S. Pond, T. Stedman, 1994, Psychopharmacology.

TREATMENT OF DIGITOXIN OVERDOSE WITH ORAL ACTIVATED CHARCOAL

S. Pond, N. Goldschlager, M. Jacobs, 1981, The Lancet.

Metabolic disposition of simvastatin in patients with T-tube drainage.

S. Pond, J. Gilbert, J. Rogers, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Microscale high-performance liquid chromatography-electrospray tandem mass spectrometry assay for cyclosporin A in blood.

S. Pond, P. Taylor, A. G. Johnson, 1998, Journal of chromatography. B, Biomedical sciences and applications.

Repeated hemoperfusion and continuous arteriovenous hemofiltration in a paraquat poisoned patient.

S. Pond, D. M. Wright, M. Bowles, 1987, Journal of toxicology. Clinical toxicology.

Hemoperfusion for Paraquat Poisoning - a Review of 42 Patients

S. Pond, E. Hampson, 1987 .

Efficacy of single or repeated hemoperfusion in a canine model of paraquat poisoning.

D. Effeney, S. Pond, E. Hampson, 1990, Journal of Pharmacology and Experimental Therapeutics.

Altered methadone pharmacokinetics in methadone-maintained pregnant women.

N. Benowitz, M. Kreek, S. Pond, 1985, The Journal of pharmacology and experimental therapeutics.

Extracorporeal techniques in the treatment of poisoned patients

S. Pond, 1991 .

Lack of effect of diazepam on methadone metabolism in methadone‐maintained addicts

N. Benowitz, P. Jacob, S. Pond, 1982, Clinical pharmacology and therapeutics.

Hemoperfusion in a child who ingested diquat and died from pontine infarction and hemorrhage.

S. Pond, A. Portale, D. Powell, 1983, Journal of toxicology. Clinical toxicology.

Cloning, expression, and purification of an anti-desipramine single chain antibody in NS/O myeloma cells.

M. Murtaugh, S. Pond, W. Shelver, 1995, Journal of pharmaceutical sciences.

An evaluation of the effects of lithium in the treatment of chronic alcoholism. I. Clinical results.

C. Peck, S. Pond, R. Bowler, 1981, Alcoholism, clinical and experimental research.

Intestinal infarction complicating phenobarbital overdose.

E. Verrier, S. Pond, M. Federle, 1984, Archives of internal medicine.

High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.

A. Grygotis, L. Shaw, S. Pond, 1997, Therapeutic drug monitoring.

Improved therapeutic drug monitoring of tacrolimus (FK506) by tandem mass spectrometry.

S. Pond, P. Taylor, N. Hogan, 1997, Clinical chemistry.

Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol

H. Whiteford, D. Eyles, S. Pond, 1992, Psychopharmacology.

Metabolic drug interactions--a critical review.

S. Pond, D. Birkett, 1975, The Medical journal of Australia.

Aging, acute oxidative injury and hepatocellular glucose transport in the rat

S. Pond, L. Rivory, D. Couteur, 1995 .

Hepatic uptake of protein-bound ligands: extended sinusoidal perfusion model.

S. Pond, R. Weisiger, L. Bass, 1991, The American journal of physiology.

Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions

D. Effeney, S. Pond, T. Tozer, 1984, Journal of Pharmacokinetics and Biopharmaceutics.

Determination of the in vivo antigen-antibody affinity constant from the redistribution of desipramine in rats following administration of a desipramine-specific monoclonal antibody.

D. Winzor, S. Pond, D J Winzor, 1991, Biochemical pharmacology.

A technique to study hepatic and intestinal drug metabolism separately in the dog.

D. Effeney, S. Pond, S. Riegelman, 1982, The Journal of pharmacology and experimental therapeutics.

Lack of gastrointestinal metabolism of propranolol in dogs after portacaval transposition.

D. Effeney, S. Pond, S. Riegelman, 1982, The Journal of pharmacology and experimental therapeutics.

The importance of electrostatic interactions in the binding of paraquat to its elicited monoclonal antibody.

S. Pond, M. Bowles, 1990, Molecular immunology.

Reversal of desipramine toxicity in rats using drug-specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate.

G. Brunn, S. Pond, D. Keyler, 1992, The Journal of pharmacology and experimental therapeutics.

Drug-specific F(ab')2 fragment reduces desipramine cardiotoxicity in rats.

G. Brunn, S. Pond, D. Keyler, 1991, International journal of immunopharmacology.

Pharmacokinetics and toxicity of high doses of antibody Fab fragments in rats.

S. Pond, D. Keyler, P. Pentel, 1988, Drug metabolism and disposition: the biological fate of chemicals.

Removal of Theophylline From the Body by Haemoperfusion

S. Pond, K. Muir, W. Tilstone, 1979, Clinical pharmacokinetics.

Glucose transport and hypoxia–reoxygenation injury in the perfused rat liver

S. Pond, L. Rivory, D. Couteur, 1994, Journal of gastroenterology and hepatology.

Lack of Efficacy of Plasmapheresis in a Patient Overdosed with Thyroxine

S. Pond, G. Ward, A. Henderson, 1994, Anaesthesia and intensive care.

A human in vivo model for the determination of lead bioavailability using stable isotope dilution.

V. Slavkovich, J. Graziano, C. Blum, 1996, Environmental health perspectives.

The Epidemiology of Parkinson’s Disease in an Australian Population

C. Brayne, A. Green, S. Pond, 1998, Neuroepidemiology.

The Serotonin Transporter Gene and Parkinson’s Disease

D. L. Le Couteur, S. Pond, G. Mellick, 2000, European Neurology.

Colchicine Overdose in 6 Patients

S. Pond, A. Henderson, Neville L. Bailey, 1993 .

Clinical and Neuropathological Abnormalities in Baboons Treated with HPTP, the Tetrahydropyridine Analog of Haloperidol

G. Halliday, S. Pond, H. Cartwright, 1999, Experimental Neurology.

Evaluation and Comparison of the TDXII, Stratus, and OPUS Digoxin Assays

S. Pond, A. G. Johnson, R. Norris, 1995, Therapeutic drug monitoring.

Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.

D. L. Le Couteur, S. Pond, D. Keyler, 1995, The Journal of pharmacology and experimental therapeutics.

The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver.

D. L. Le Couteur, S. Pond, L. Rivory, 1994, Transplantation.

An open-label study of famotidine as a treatment for schizophrenia.

H. Whiteford, J. Welham, S. Pond, 1995, Journal of psychiatry & neuroscience : JPN.

Ethylesterases as indicators of liver damage. I. Studies on malathion carboxylesterases.

S. Pond, A. Ketterman, C. Becker, 1982, Toxicology and applied pharmacology.

Granulomatous thyroiditis and lithium therapy.

S. Pond, M. Sinnott, H. Mcintyre, 1992, Australian and New Zealand journal of medicine.

Severe botulism after eating home‐preserved asparagus

M. Whitby, S. Pond, R. Boyle, 1992, The Medical journal of Australia.

Manual of toxicologic emergencies

S. Pond, 1990 .

"Profiting" from vegetables.

S. Pond, 1996, Journal of toxicology. Clinical toxicology.

Clinical applicability of current pharmacokinetic models: Splanchnic elimination of 5-fluorouracil in cancer patients

J. Wagner, P. Robinson, M. Roberts, 1988, Journal of Pharmacokinetics and Biopharmaceutics.

Mathematical modelling of the impact of haematopoietic stem cell‐delivered gene therapy for HIV

J. Macpherson, S. Pond, J. Murray, 2009, The journal of gene medicine.

The midbrain dopaminergic cell groups in the baboon papio ursinus

G. Halliday, S. Pond, H. Cartwright, 1998, Brain Research Bulletin.

Long-term treatment with the tetrahydropyridine analog (HPTP) of haloperidol influences dopamine ligand binding in baboon brain. An [123I]iodobenzamide (IBZM) SPECT study.

H. Müller-Gärtner, S. Pond, N. Castagnoli, 1996, Brain research. Molecular brain research.

Changes in methadone pharmacokinetics during pregnancy

N. Benowitz, M. Kreek, S. Pond, 1982 .

Competition between paraquat and putrescine for uptake by suspensions of rat alveolar type II cells.

S. Pond, M. Bowles, N. Chen, 1992, Biochemical pharmacology.

Cloning and analysis of a cDNA encoding a human liver carboxylesterase.

S. Pond, M. Bowles, P. Riddles, 1991, Gene.

Pretreatment with drug-specific antibody reduces desipramine cardiotoxicity in rats.

G. Brunn, S. Pond, D. Keyler, 1991, Life sciences.

Diazepam kinetics in acute alcohol withdrawal

N. Benowitz, S. Pond, C. E. Becker, 1979, Clinical pharmacology and therapeutics.

Comparison of High‐Performance Liquid Chromatography and Monoclonal Fluorescence Polarization Immunoassay for the Determination of Whole‐Blood Cyclosporin A in Liver and Heart Transplant Patients

S. Pond, P. Taylor, P. Ravenscroft, 1994, Therapeutic drug monitoring.